Department of Obstetrics, Gynecology, and Reproductive Biology, Michigan State University, East Lansing, Michigan.
Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, Michigan.
Fertil Steril. 2014 Sep;102(3):744-52. doi: 10.1016/j.fertnstert.2014.05.020. Epub 2014 Jun 14.
To develop a model predictive of live-birth rates (LBR) and multiple birth rates (MBR) for an individual considering assisted reproduction technology (ART) using linked cycles from Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) for 2004-2011.
Longitudinal cohort.
Clinic-based data.
PATIENT(S): 288,161 women with an initial autologous cycle, of whom 89,855 did not become pregnant and had a second autologous cycle and 39,334 did not become pregnant in the first and second cycles and had a third autologous cycle, with an additional 33,598 women who had a cycle using donor oocytes (first donor cycle).
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): LBRs and MBRs modeled by woman's age, body mass index, gravidity, prior full-term births, infertility diagnoses by oocyte source, fresh embryos transferred, and cycle, using backward-stepping logistic regression with results presented as adjusted odds ratios (AORs) and 95% confidence intervals.
RESULT(S): The LBRs increased in all models with prior full-term births, number of embryos transferred; in autologous cycles also with gravidity, diagnoses of male factor, and ovulation disorders; and in donor cycles also with the diagnosis of diminished ovarian reserve. The MBR increased in all models with number of embryos transferred and in donor cycles also with prior full-term births. For both autologous and donor cycles, transferring two versus one embryo greatly increased the probability of a multiple birth (AOR 27.25 and 38.90, respectively).
CONCLUSION(S): This validated predictive model will be implemented on the Society for Assisted Reproductive Technology Web site (www.sart.org) so that patients considering initiating a course of ART can input their data on the Web site to generate their expected outcomes.
利用 2004-2011 年美国生殖医学协会临床成果报告系统(SART CORS)中辅助生殖技术(ART)相关联的周期数据,建立一个预测个体活产率(LBR)和多胎率(MBR)的模型。
纵向队列研究。
基于临床的数据。
288161 名接受初始自体周期的女性,其中 89855 名未妊娠并进行了第二次自体周期,39334 名在第一和第二周期均未妊娠并进行了第三次自体周期,另有 33598 名女性进行了供卵周期(首次供卵周期)。
无。
采用逐步向后的逻辑回归分析,以女性年龄、体重指数、孕次、既往足月产、卵源不孕诊断、新鲜胚胎移植数和周期为自变量,建立模型预测活产率和多胎率,并以调整优势比(AOR)和 95%置信区间表示结果。
所有模型中,既往足月产、胚胎移植数增加时活产率均增加;在自体周期中,孕次、男性因素和排卵障碍诊断增加时活产率也增加;在供卵周期中,诊断为卵巢储备功能减退时活产率也增加。所有模型中,胚胎移植数增加时多胎率增加;在供卵周期中,既往足月产时多胎率也增加。对于自体和供卵周期,移植 2 个胚胎与移植 1 个胚胎相比,多胎妊娠的可能性大大增加(AOR 分别为 27.25 和 38.90)。
该验证后的预测模型将在生殖医学协会网站(www.sart.org)上实施,以便考虑开始 ART 治疗的患者可以在网站上输入他们的数据,以生成预期的治疗结果。